Alembic Pharmaceuticals Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Alembic Pharmaceuticals Limited Company Profile :

Alembic Pharmaceuticals Limited is an Indian pharmaceutical company which focuses on anti-infective, analgesic and, cough and cold markets. It also focuses on chronic therapies (cardiology, diabetes, gynecology, gastrointestinal (GI), orthopedic, dermatology and respiratory).

Its segments include Active Pharmaceutical Ingredients (API), Bulk Pharma Chemicals, Formulations, and Contract/Collaborated Research Services.

The Company has five manufacturing facilities. Company not only caters the domestic market but also exports its products to over 75 countries around the world.


Alembic Pharmaceuticals ResultsBSE Code : 533573
NSE Symbol : APLLTD
ISIN No. : INE901L01018
Industry : Pharmaceuticals
Face Value : Rs. 2.00


If you are an investor who has shares of Alembic Pharmaceuticals or you are an stock market analyst then i am sure you might for Quarterly Results of Alembic Pharmaceuticals.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Alembic Pharmaceuticals. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Alembic Pharmaceuticals.

Alembic Pharmaceuticals Q1 Results 2016-17 :

Alembic Pharmaceuticals will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the company announces its results.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Alembic Pharmaceuticals will announce its Q2 FY 2016-17 Results in the month of October 2016.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Alembic Pharmaceuticals will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Alembic Pharmaceuticals will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Alembic Pharmaceuticals will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 FY 2016-17
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Alembic Pharmaceuticals Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 2991.74 3145.12
Other Income 5.51 3.59
Total Income 2997.25 3148.71
Expenditure -2009.73 -2214.95
Interest -2.37 -3.68
Depreciation -71.86 -72.21
PBT 913.29 935.59
Tax -215.17 -216.01
Net Profit 698.12 719.58
Equity 37.70 37.70
EPS 37.03 38.16

Note : If you like this information about Alembic Pharmaceuticals Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.